BRCA1 and breast carcinoma: We initiated a prospective cohort study to collect nipple aspirate fluid (NAF), DL fluid and blood samples from women with germline BRCA1/2 mutations with the aim of establishing a biorepository of samples to be used to identify biomarkers of breast cancer risk.